The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
Our study shows a potential benefit of treprostinil use in moderate-to-severe BPD-PH; larger studies are needed to validate our findings and guide decision-making around treprostinil initiation and duration.
Authors
- Roberta L. Keller (ORCID: https://orcid.org/0000-0003-0743-8470)
- Hythem Nawaytou (ORCID: https://orcid.org/0000-0002-9155-2665)
- Mariam Taleb
- Elizabeth Colglazier (ORCID: https://orcid.org/0000-0001-7517-0299)
- Elena K. Amin (ORCID: https://orcid.org/0000-0002-7698-278X)
- Shannon Cheung
- Claire Parker (ORCID: https://orcid.org/0000-0002-8431-7130)
- Jeffrey R. Fineman
- Stephanie M. Tsoi
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/ppul.71448
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health